Insider Transactions in Q1 2022 at Treace Medical Concepts, Inc. (TMCI)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 10
2022
|
James T Treace |
SELL
Open market or private sale
|
Indirect |
2
-100.0%
|
$38
$19.2 P/Share
|
|
Mar 10
2022
|
Richard W Mott |
SELL
Bona fide gift
|
Direct |
105,000
-6.18%
|
-
|
|
Mar 08
2022
|
Scot Michael Elder Chief Legl & Comp Off, CorpSec |
BUY
Grant, award, or other acquisition
|
Direct |
2,875
+18.25%
|
-
|
|
Mar 08
2022
|
Aaron Berutti SVP, Sales |
BUY
Grant, award, or other acquisition
|
Direct |
11,950
+50.0%
|
-
|
|
Mar 08
2022
|
Jaime A. Frias Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,875
+13.45%
|
-
|
|
Mar 08
2022
|
Mark Hair Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,950
+35.25%
|
-
|
|
Mar 08
2022
|
John T. Treace Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
33,875
+0.62%
|
-
|
|
Mar 08
2022
|
Terry W. Lubben SVP, Operations |
BUY
Open market or private purchase
|
Direct |
2,500
+29.94%
|
$45,000
$18.62 P/Share
|
|
Mar 08
2022
|
Terry W. Lubben SVP, Operations |
BUY
Grant, award, or other acquisition
|
Direct |
3,350
+50.0%
|
-
|
|
Mar 08
2022
|
Sean F. Scanlan Chief Innovation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,575
+50.0%
|
-
|
|
Mar 08
2022
|
Daniel E. Owens |
BUY
Grant, award, or other acquisition
|
Direct |
6,700
+38.51%
|
-
|
|
Mar 02
2022
|
Sean F. Scanlan Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
25,000
-100.0%
|
$500,000
$20.82 P/Share
|
|
Mar 02
2022
|
Sean F. Scanlan Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+50.0%
|
$25,000
$1.05 P/Share
|
|
Feb 09
2022
|
Sean F. Scanlan Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
3,873
-100.0%
|
$77,460
$20.16 P/Share
|
|
Feb 09
2022
|
Sean F. Scanlan Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,873
+50.0%
|
$3,873
$1.05 P/Share
|
|
Feb 08
2022
|
Sean F. Scanlan Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
21,127
-100.0%
|
$422,540
$20.02 P/Share
|
|
Feb 08
2022
|
Sean F. Scanlan Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,127
+50.0%
|
$21,127
$1.05 P/Share
|
|
Feb 04
2022
|
James T Treace |
SELL
Bona fide gift
|
Indirect |
450,000
-44.72%
|
-
|
|
Jan 19
2022
|
James T Treace |
SELL
Open market or private sale
|
Direct |
32,063
-2.26%
|
$577,134
$18.99 P/Share
|
|
Jan 18
2022
|
James T Treace |
SELL
Open market or private sale
|
Direct |
42,937
-1.47%
|
$815,803
$19.68 P/Share
|
|
Jan 13
2022
|
Thomas E Timbie Director |
SELL
Bona fide gift
|
Indirect |
95,000
-15.83%
|
-
|
|
Jan 11
2022
|
Sean F. Scanlan Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
8,838
-100.0%
|
$176,760
$20.12 P/Share
|
|
Jan 11
2022
|
Sean F. Scanlan Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,838
+46.03%
|
$8,838
$1.31 P/Share
|
|
Jan 10
2022
|
Sean F. Scanlan Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
38,862
-100.0%
|
$777,240
$20.16 P/Share
|
|
Jan 10
2022
|
Sean F. Scanlan Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
38,862
+47.04%
|
$38,862
$1.57 P/Share
|
|
Jan 05
2022
|
Sean F. Scanlan Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
800
-100.0%
|
$16,000
$20.02 P/Share
|
|
Jan 05
2022
|
Sean F. Scanlan Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
800
+50.0%
|
$800
$1.57 P/Share
|
|
Jan 04
2022
|
Sean F. Scanlan Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
500
-100.0%
|
$10,000
$20.0 P/Share
|
|
Jan 04
2022
|
Sean F. Scanlan Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+50.0%
|
$500
$1.57 P/Share
|
|
Jan 03
2022
|
Sean F. Scanlan Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
1,000
-100.0%
|
$20,000
$20.02 P/Share
|
|
Jan 03
2022
|
Sean F. Scanlan Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+50.0%
|
$1,000
$1.57 P/Share
|